TUCSON, Ariz., April 9, 2019 — Critical Path Institute’s (C-Path) Patient-Reported Outcome (PRO) Consortium announces U.S. Food and Drug Administration (FDA) qualification of two new clinical outcome assessment tools: the Asthma Daytime Symptom Diary (ADSD) and the Asthma Nighttime Symptom Diary (ANSD). The qualification of the ADSD and the ANSD represents a major milestone for the PRO Consortium and specifically for the Asthma Working Group. It is the culmination of a multi-year collaboration between FDA’s Center for Drug Evaluation and Research (CDER) and the PRO Consortium.
Category Archives: AZBio News
Senator Sinema Honored as Innovator in Biotechnology
Washington, D.C. (April 3, 2019) – Senator Kyrsten Sinema was recognized today by the Biotechnology Innovation Organization (BIO) for her leadership as an Innovator in Biotechnology. Senator Sinema received the award in conjunction with today’s BIO Legislative Day Fly-In.Continue reading
Exploring Copper’s Potential as Antibiotic
While antibiotic resistance is on the rise, pharmaceutical companies are making fewer and fewer new antibiotics. UA immunobiologist Michael Johnson says this trend is in urgent need of reversal and believes copper might just be the key.Continue reading
C-Path President and CEO, Board Director Selected to Serve on Esteemed National Academies of Sciences, Engineering and Medicine Committee
C-Path President and CEO Martha Brumfield, PhD, and C-Path Board Director Alastair J. Wood, MD, FRCP, have both been selected to the serve on the National Academy Consensus Committee examining Mutual Recognition Agreements in the Regulation of Medicines under The National Academies of Sciences, Engineering and Medicine. Dr. Wood will serve as chair.
Flinn Foundation to fund in-depth bioscience reporting by The Arizona Republic
The Flinn Foundation and The Arizona Republic have entered into a grant-based partnership that will enable the state’s largest media platform to pursue a multimedia initiative to deepen public understanding of the biosciences in Arizona, including research, industry development, and clinical advances.Continue reading
HTG Introduces the HTG EdgeSeq Mouse mRNA Tumor Response Panel
HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, announced it has released a new HTG EdgeSeq Mouse mRNA Tumor Response Panel available now in the United States and Europe. Continue reading
Stryker’s Chairman and CEO Kevin Lobo Named Chairman of AdvaMed Board of Directors
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today announced that Stryker’s Chairman and CEO Kevin Lobo has been named chairman of the AdvaMed Board of Directors for a two-year term.
Banner Health experts offer valuable community info about measles
Get the information and watch the video to learn more about vaccines, symptoms, and who is at riskContinue reading
UA Physician and iTether Create App for Pregnant Women, New Moms, with Opioid Addiction
Grant allows for development of new online platform which will be a cell phone app for pregnant women and new moms struggling with opioid addiction is helping them get to doctor appointments on time, chat online with counselors, message their physician and watch videos that teach them about changing their behavior.Continue reading